UNIVERSITY OF FLORIDA

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1853-01-01

Employees: 10K

Market Cap: -

Website: http://www.ufl.edu

Clinical Trials

RHAPSody: Diagnostic Utility of RUSH Following ROSC

Terminated

Conditions: Cardiac Arrest

Interventions: Device: RUSH Exam

First Posted Date: 2018-01-24

Last Posted Date: 2022-12-27

Lead Sponsor: University of Florida

Target Recruit Count: 5

Registration Number: NCT03409289

Locations: 🇺🇸
University of Florida Health (UFHealth), Gainesville, Florida, United States

LIPIDS-P Trial Phase I/II

Phase 1

Recruiting

Conditions: Sepsis, Severe
Septic Shock

Interventions: Drug: Smoflipid

First Posted Date: 2018-01-23

Last Posted Date: 2022-01-12

Lead Sponsor: University of Florida

Target Recruit Count: 68

Registration Number: NCT03405870

Locations: 🇺🇸
UF Health Jacksonville North campus, Jacksonville, Florida, United States
🇺🇸
Department of Emergency Medicine, UF Health Jax ICU/MICU, Jacksonville, Florida, United States
🇺🇸
UF Health Jacksonville, Jacksonville, Florida, United States

A Patient-centered Intervention Using Technology to Reduce Colorectal Cancer Disparities in Primary Care

Not Applicable

Completed

Conditions: Colo-rectal Cancer

Interventions: Other: virtual technology - tailored minimally
Other: virtual technology - highly tailored

First Posted Date: 2018-01-23

Last Posted Date: 2024-06-06

Lead Sponsor: University of Florida

Target Recruit Count: 3300

Registration Number: NCT03407417

Locations: 🇺🇸
University of Florida, Jacksonville, Florida, United States

Study Testing The Safety and Efficacy of Adjuvant Temozolomide Plus TTFields (Optune®) Plus Pembrolizumab in Patients With Newly Diagnosed Glioblastoma (2-THE-TOP)

Phase 2

Active, not recruiting

Conditions: Glioblastoma
Glioblastoma, WHO Grade IV

Interventions: Drug: Temozolomide (TMZ)
Device: Optune System
Drug: Pembrolizumab

First Posted Date: 2018-01-23

Last Posted Date: 2024-10-23

Lead Sponsor: University of Florida

Target Recruit Count: 40

Registration Number: NCT03405792

Locations: 🇺🇸
University of Florida Health, Gainesville, Florida, United States

Peripheral Nerve Blocks for Above-the-knee Amputations

Phase 4

Recruiting

Conditions: Peripheral Vascular Diseases
Hypertension
Hyperglycaemia (Diabetic)
Coronary Artery Disease
Pulmonary Disease, Chronic Obstructive

Interventions: Procedure: Peripheral nerve block
Drug: Intravenous Sedatives
Procedure: Lateral femoral cutaneous nerve blocks
Procedure: Obturator nerve blocks

First Posted Date: 2018-01-19

Last Posted Date: 2024-08-26

Lead Sponsor: University of Florida

Target Recruit Count: 36

Registration Number: NCT03404180

Locations: 🇺🇸
University of Florida, Gainesville, Florida, United States

Brain Stem Gliomas Treated With Adoptive Cellular Therapy During Focal Radiotherapy Recovery Alone or With Dose-intensified Temozolomide (Phase I)

Phase 1

Active, not recruiting

Conditions: Diffuse Intrinsic Pontine Glioma (DIPG)
Brain Stem Glioma

Interventions: Biological: TTRNA-DC vaccines with GM-CSF
Biological: TTRNA-xALT
Drug: Dose-Intensified TMZ
Drug: Cyclophosphamide + Fludarabine Lymphodepletive Conditioning
Drug: Td vaccine
Biological: Autologous Hematopoietic Stem Cells (HSC)

First Posted Date: 2018-01-11

Last Posted Date: 2024-11-19

Lead Sponsor: University of Florida

Target Recruit Count: 21

Registration Number: NCT03396575

Locations: 🇺🇸
UF Health Shands Children's Hospital, Gainesville, Florida, United States

Radiotherapy Dose Escalation in Locally Advanced Squamous Cell Carcinoma of the Larynx or Hypopharynx

Phase 4

Withdrawn

Conditions: Advanced Squamous Cell Carcinoma

Interventions: Radiation: Radiation Therapy
Combination Product: Chemotherapy

First Posted Date: 2018-01-03

Last Posted Date: 2019-05-13

Lead Sponsor: University of Florida

Registration Number: NCT03388931

Locations: 🇺🇸
University of Florida, Gainesville, Florida, United States

Digital Rehabilitation Environment Augmenting Medical System

Not Applicable

Active, not recruiting

Conditions: Delirium

Interventions: Device: Technology based guided meditation and relaxation

First Posted Date: 2017-12-29

Last Posted Date: 2024-06-18

Lead Sponsor: University of Florida

Target Recruit Count: 100

Registration Number: NCT03385993

Locations: 🇺🇸
UF Health, Gainesville, Florida, United States

Therapeutic Oxygen for Gastrointestinal Atony (TOGA)

Phase 1

Completed

Conditions: Ileus
Small Bowel Obstruction
Ogilvie Syndrome

Interventions: Drug: 100% Oxygen

First Posted Date: 2017-12-29

Last Posted Date: 2019-12-12

Lead Sponsor: University of Florida

Target Recruit Count: 17

Registration Number: NCT03386136

Locations: 🇺🇸
University of Florida, Gainesville, Florida, United States

Duration of Analgesia With Dexmedetomidine and Ropivacaine in Brachial Plexus Block

Phase 4

Withdrawn

Conditions: Analgesia
Peripheral Nerve Block
Pain, Acute

Interventions: Drug: ropivacaine
Drug: Dexmedetomidine

First Posted Date: 2017-12-29

Last Posted Date: 2019-05-23

Lead Sponsor: University of Florida

Registration Number: NCT03385967

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy